Product Information

HUMIRA(CF) 20 MG/0.2 ML SYRINGE is a brand product labeled by AbbVie Inc., priced at $3366.1230 per EA under NDC 00074061602. Its NADAC has been published 123 times since Apr 17, 2024.

HUMIRA(CF) 20 MG/0.2 ML SYRINGE

Adalimumab
$3366.1230per EA

Manufacturer

AbbVie Inc.

NDC

00074061602

Classification

Brand

Dosage Form

KIT

Effective Date

5/20/2026

Approval Type

Biologic (BLA)

FDA Application

BLA125057

On Market Since

4/28/2017

Price Statistics

The NADAC for HUMIRA(CF) 20 MG/0.2 ML SYRINGE has been published 123 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$3366.1230 per EA
All-time high$3374.7750 (Aug 13, 2025)
All-time low$3340.6945 (Feb 19, 2025)
52-week high$3371.0664
52-week low$3366.1230
Median price$3366.1230
Average price$3363.7018
Largest weekly change+0.8% (Jun 18, 2025)
Weeks tracked123
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.1%

3Y

N/A

5Y

N/A

All

-0.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of HUMIRA(CF) 20 MG/0.2 ML SYRINGE?

The current National Average Drug Acquisition Cost (NADAC) for HUMIRA(CF) 20 MG/0.2 ML SYRINGE, manufactured by AbbVie Inc., is $3366.1230 per EA (NDC 00074061602), effective Aug 19, 2026.

How has the price of HUMIRA(CF) 20 MG/0.2 ML SYRINGE changed over time?

Over the history we have for it, the NADAC for HUMIRA(CF) 20 MG/0.2 ML SYRINGE has held within roughly two percent of its current level. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for HUMIRA(CF) 20 MG/0.2 ML SYRINGE?

Since Apr 17, 2024, the NADAC for HUMIRA(CF) 20 MG/0.2 ML SYRINGE has ranged from a low of $3340.6945 (Feb 19, 2025) to a high of $3374.7750 (Aug 13, 2025), with a median of $3366.1230 per EA.

Are there cheaper alternatives to HUMIRA(CF) 20 MG/0.2 ML SYRINGE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HUMIRA(CF) 20 MG/0.2 ML SYRINGE in a comparable dosage form, but none are currently priced below it.

Who manufactures HUMIRA(CF) 20 MG/0.2 ML SYRINGE?

HUMIRA(CF) 20 MG/0.2 ML SYRINGE (NDC 00074061602) is labeled by AbbVie Inc., and CMS classifies it as a brand product.